CytoDyn Inc. Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset
CytoDyn Inc. (CYDY) reported Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset of $3.54 million for the 12-month period ending 2019-05-31, per its 10-K filed 2021-07-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset · last filed 2021-07-30
- CytoDyn Inc. consideration received for beneficial interest obtained for transferring financial asset for the quarter ending 2019-05-31 was $8.00.
- CytoDyn Inc. consideration received for beneficial interest obtained for transferring financial asset for the quarter ending 2018-05-31 was $0.00.
- CytoDyn Inc. consideration received for beneficial interest obtained for transferring financial asset for fiscal 2019 was $3.54M.
- CytoDyn Inc. consideration received for beneficial interest obtained for transferring financial asset for fiscal 2018 was $0.00.
- CytoDyn Inc. consideration received for beneficial interest obtained for transferring financial asset for fiscal 2017 was $0.00.
| Period end | Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset 3 month | Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset 9 month | Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset 12 month | Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset 12 month as first filed |
|---|---|---|---|---|
| 2019-05-31 | $8.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $3.54M 10-K · filed 2021-07-30 | $3.53M 10-K · filed 2019-08-14 | |
| 2019-02-28 | $3.53M 10-Q · filed 2020-04-09 | |||
| 2018-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-14 | $0.00 10-K · filed 2019-08-14 | ||
| 2018-02-28 | $0.00 10-Q · filed 2019-04-09 | |||
| 2017-05-31 | $0.00 10-K · filed 2019-08-14 |